COCRYSTAL PHARMA, INC. Net Income (Loss) Attributable to Parent, Diluted
COCRYSTAL PHARMA, INC. (COCP) reported Net Income (Loss) Attributable to Parent, Diluted of -$613.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-21.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToParentDiluted · last filed 2018-03-21
- COCRYSTAL PHARMA, INC. net income (loss) attributable to parent, diluted for fiscal 2017 was -$613.00K.
- COCRYSTAL PHARMA, INC. net income (loss) attributable to parent, diluted for fiscal 2016 was -$77.48M.
- COCRYSTAL PHARMA, INC. net income (loss) attributable to parent, diluted for fiscal 2015 was -$50.12M.
- COCRYSTAL PHARMA, INC. net income (loss) attributable to parent, diluted for fiscal 2014 was -$2.33M.
| Period end | Net Income (Loss) Attributable to Parent, Diluted 12 month | Net Income (Loss) Attributable to Parent, Diluted 12 month as first filed |
|---|---|---|
| 2017-12-31 | -$613.00K 10-K · filed 2018-03-21 | |
| 2016-12-31 | -$77.48M 10-K · filed 2018-03-21 | |
| 2015-12-31 | -$50.12M 10-K · filed 2018-03-21 | |
| 2014-12-31 | -$2.33M 10-K · filed 2017-03-31 | |
| 2013-12-31 | -$3.89M 10-K · filed 2015-03-31 | -$23.76M 10-K · filed 2014-03-31 |
| 2012-12-31 | -$7.96M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |